2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$7.66+$0.24 (+3.29%)
Price as of Oct 02, 2026 5:23 PM EDT- $489.8MMarket Cap
- -29.87%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$7.66+$0.24 (+3.29%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.42 | ||
Change | -$0.11 (-1.46%) | ||
Open | $7.52 | ||
High | $7.74 | ||
Low | $7.30 | ||
Previous Close | $7.53 | ||
Volume | 1,705,150 | ||
30-Day Average Volume | 1,363,419 | ||
1-Week Change | 2.49% | ||
1-Month Change | -20.39% | ||
1-Year Change | -29.87% | ||
3-Year Change | -54.92% | ||
5-Year Change | -81.58% | ||
Fundamentals | |||
Shares Outstanding | 66.0M | ||
Total Assets | $386.6M | ||
Market Cap | $489.8M | ||
Enterprise Value | $453.3M | ||
Period: QTR TTM FY | |||
Revenue | $103.8M | ||
Net Income | $22.7M | ||
Free Cash Flow | -$63.0M | ||
EBIT | $22.7M | ||
EBITDA | $26.5M | ||
Net Working Capital | $153.5M | ||
EPS | $0.43 | ||
Enterprise Value/EBITDA | 17 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 7 | ||
P/E | 17 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue